Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
Condition(s):Essential HypertensionLast Updated:December 10, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Essential HypertensionLast Updated:December 10, 2010Completed
Condition(s):HypertensionLast Updated:September 25, 2014Completed
Condition(s):HypertensionLast Updated:December 9, 2013Completed
Condition(s):Essential HypertensionLast Updated:September 18, 2023Not yet recruiting
Condition(s):HypertensionLast Updated:November 5, 2013Completed
Condition(s):Essential HypertensionLast Updated:February 7, 2012Completed
Condition(s):Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under TreatmentLast Updated:June 28, 2021Completed
Condition(s):HypertensionLast Updated:March 28, 2016Completed
Condition(s):High Blood Pressure (Hypertension).Last Updated:March 25, 2009Completed
Condition(s):HypertensionLast Updated:June 28, 2022Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.